Literature DB >> 18852456

Nicotine decreases DNA methyltransferase 1 expression and glutamic acid decarboxylase 67 promoter methylation in GABAergic interneurons.

R Satta1, E Maloku, A Zhubi, F Pibiri, M Hajos, E Costa, A Guidotti.   

Abstract

Tobacco smoking is frequently abused by schizophrenia patients (SZP). The major synaptically active component inhaled from cigarettes is nicotine, hence the smoking habit of SZP may represent an attempt to use nicotine self-medication to correct (i) a central nervous system nicotinic acetylcholine receptor (nAChR) dysfunction, (ii) DNA-methyltransferase 1 (DMT1) overexpression in GABAergic neurons, and (iii) the down-regulation of reelin and GAD(67) expression caused by the increase of DNMT1-mediated hypermethylation of promoters in GABAergic interneurons of the telencephalon. Nicotine (4.5-22 micromol/kg s.c., 4 injections during the 12-h light cycle for 4 days) decreases DNMT1 mRNA and protein and increases GAD(67) expression in the mouse frontal cortex (FC). This nicotine-induced decrease of DNMT1 mRNA expression is greater (80%) in laser microdissected FC layer I GABAergic neurons than in the whole FC (40%), suggesting selectivity differences for the specific nicotinic receptor populations expressed in GABAergic neurons of different cortical layers. The down-regulation of DNMT1 expression induced by nicotine in the FC is also observed in the hippocampus but not in striatal GABAergic neurons. Furthermore, these data show that in the FC, the same doses of nicotine that decrease DNMT1 expression also (i) diminished the level of cytosine-5-methylation in the GAD(67) promoter and (ii) prevented the methionine-induced hypermethylation of the same promoter. Pretreatment with mecamylamine (6 micromol/kg s.c.), an nAChR blocker that penetrates the blood-brain barrier, prevents the nicotine-induced decrease of FC DNMT1 expression. Taken together, these results suggest that nicotine, by activating nAChRs located on cortical or hippocampal GABAergic interneurons, can up-regulate GAD(67) expression via an epigenetic mechanism. Nicotine is not effective in striatal medium spiny GABAergic neurons that primarily express muscarinic receptors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18852456      PMCID: PMC2570996          DOI: 10.1073/pnas.0808699105

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  Reelin and glutamic acid decarboxylase67 promoter remodeling in an epigenetic methionine-induced mouse model of schizophrenia.

Authors:  E Dong; R C Agis-Balboa; M V Simonini; D R Grayson; E Costa; A Guidotti
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-19       Impact factor: 11.205

2.  Ligands selective for alpha4beta2 but not alpha3beta4 or alpha7 nicotinic receptors generalise to the nicotine discriminative stimulus in the rat.

Authors:  Janice W Smith; Adrian Mogg; Elisiana Tafi; Eleanor Peacey; Ian A Pullar; Philip Szekeres; Mark Tricklebank
Journal:  Psychopharmacology (Berl)       Date:  2006-11-18       Impact factor: 4.530

3.  Design, synthesis, structure-activity relationship, and in vivo activity of azabicyclic aryl amides as alpha7 nicotinic acetylcholine receptor agonists.

Authors:  Daniel P Walker; Donn G Wishka; David W Piotrowski; Shaojuan Jia; Steven C Reitz; Karen M Yates; Jason K Myers; Tatiana N Vetman; Brandon J Margolis; E Jon Jacobsen; Brad A Acker; Vincent E Groppi; Mark L Wolfe; Bruce A Thornburgh; Paula M Tinholt; Luz A Cortes-Burgos; Rodney R Walters; Matthew R Hester; Eric P Seest; Lester A Dolak; Fusen Han; Barbara A Olson; Laura Fitzgerald; Brian A Staton; Thomas J Raub; Mihaly Hajos; William E Hoffmann; Kai S Li; Nicole R Higdon; Theron M Wall; Raymond S Hurst; Erik H F Wong; Bruce N Rogers
Journal:  Bioorg Med Chem       Date:  2006-10-02       Impact factor: 3.641

Review 4.  GABAergic dysfunction in schizophrenia: new treatment strategies on the horizon.

Authors:  Alessandro Guidotti; James Auta; John M Davis; Erbo Dong; Dennis R Grayson; Marin Veldic; Xianquan Zhang; Erminio Costa
Journal:  Psychopharmacology (Berl)       Date:  2005-04-28       Impact factor: 4.530

Review 5.  Cortical inhibitory neurons and schizophrenia.

Authors:  David A Lewis; Takanori Hashimoto; David W Volk
Journal:  Nat Rev Neurosci       Date:  2005-04       Impact factor: 34.870

6.  Valproate corrects the schizophrenia-like epigenetic behavioral modifications induced by methionine in mice.

Authors:  Lucio Tremolizzo; Mohemed-Salim Doueiri; Erbo Dong; Dennis R Grayson; John Davis; Graziano Pinna; Patricia Tueting; Virginia Rodriguez-Menendez; Erminio Costa; Alessandro Guidotti
Journal:  Biol Psychiatry       Date:  2005-03-01       Impact factor: 13.382

7.  Nicotine activates and desensitizes midbrain dopamine neurons.

Authors:  V I Pidoplichko; M DeBiasi; J T Williams; J A Dani
Journal:  Nature       Date:  1997-11-27       Impact factor: 49.962

Review 8.  Alpha-7 nicotinic receptor agonists: potential new candidates for the treatment of schizophrenia.

Authors:  Laura F Martin; William R Kem; Robert Freedman
Journal:  Psychopharmacology (Berl)       Date:  2004-02-19       Impact factor: 4.530

9.  Mediation of nicotine-induced convulsions by central nicotinic receptors of the 'C6' type.

Authors:  M P Caulfield; G A Higgins
Journal:  Neuropharmacology       Date:  1983-03       Impact factor: 5.250

10.  GABAA receptor subunit gene expression in human prefrontal cortex: comparison of schizophrenics and controls.

Authors:  S Akbarian; M M Huntsman; J J Kim; A Tafazzoli; S G Potkin; W E Bunney; E G Jones
Journal:  Cereb Cortex       Date:  1995 Nov-Dec       Impact factor: 5.357

View more
  81 in total

1.  Variable DNA methylation is associated with chronic obstructive pulmonary disease and lung function.

Authors:  Weiliang Qiu; Andrea Baccarelli; Vincent J Carey; Nadia Boutaoui; Helene Bacherman; Barbara Klanderman; Stephen Rennard; Alvar Agusti; Wayne Anderson; David A Lomas; Dawn L DeMeo
Journal:  Am J Respir Crit Care Med       Date:  2011-12-08       Impact factor: 21.405

Review 2.  Neuroimaging insights into the role of cortical GABA systems and the influence of nicotine on the recovery from alcohol dependence.

Authors:  Kelly P Cosgrove; Irina Esterlis; Graeme F Mason; Frederic Bois; Stephanie S O'Malley; John H Krystal
Journal:  Neuropharmacology       Date:  2011-01-27       Impact factor: 5.250

3.  DNA methyltransferases1 (DNMT1) and 3a (DNMT3a) colocalize with GAD67-positive neurons in the GAD67-GFP mouse brain.

Authors:  Bashkim Kadriu; Alessandro Guidotti; Ying Chen; Dennis R Grayson
Journal:  J Comp Neurol       Date:  2012-06-15       Impact factor: 3.215

4.  Epigenetics in the human brain.

Authors:  Isaac Houston; Cyril J Peter; Amanda Mitchell; Juerg Straubhaar; Evgeny Rogaev; Schahram Akbarian
Journal:  Neuropsychopharmacology       Date:  2012-05-30       Impact factor: 7.853

Review 5.  Epigenetic GABAergic targets in schizophrenia and bipolar disorder.

Authors:  A Guidotti; J Auta; Y Chen; J M Davis; E Dong; D P Gavin; D R Grayson; F Matrisciano; G Pinna; R Satta; R P Sharma; L Tremolizzo; P Tueting
Journal:  Neuropharmacology       Date:  2010-11-11       Impact factor: 5.250

6.  Lynx1, a cholinergic brake, limits plasticity in adult visual cortex.

Authors:  Hirofumi Morishita; Julie M Miwa; Nathaniel Heintz; Takao K Hensch
Journal:  Science       Date:  2010-11-11       Impact factor: 47.728

7.  Nicotine restores Wt-like levels of reelin and GAD67 gene expression in brain of heterozygous reeler mice.

Authors:  Emilia Romano; Andrea Fuso; Giovanni Laviola
Journal:  Neurotox Res       Date:  2013-02-06       Impact factor: 3.911

8.  Chronic nicotine exposure augments renal oxidative stress and injury through transcriptional activation of p66shc.

Authors:  Istvan Arany; Jeb Clark; Dustin K Reed; Luis A Juncos
Journal:  Nephrol Dial Transplant       Date:  2013-01-16       Impact factor: 5.992

9.  Reduced density of calbindin immunoreactive GABAergic neurons in the occipital cortex in major depression: relevance to neuroimaging studies.

Authors:  Dorota Maciag; Jonathan Hughes; Gillian O'Dwyer; Yilianys Pride; Craig A Stockmeier; Gerard Sanacora; Grazyna Rajkowska
Journal:  Biol Psychiatry       Date:  2009-12-09       Impact factor: 13.382

Review 10.  Pharmacology of epigenetics in brain disorders.

Authors:  Pritika Narayan; Mike Dragunow
Journal:  Br J Pharmacol       Date:  2009-12-15       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.